'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for vancomycin': authors' reply

被引：9
|
作者：
Lee, Brian V. [1 ]
Fong, Gary [2 ,4 ,8 ]
Bolaris, Michael [3 ,4 ]
Neely, Michael [5 ,6 ,7 ]
Minejima, Emi [1 ]
Kang, Amy [2 ,4 ,8 ]
Lee, Grace [8 ]
Gong, Cynthia L. [6 ,9 ,10 ]
机构：
[1] Univ Southern Calif, Sch Pharm, Los Angeles, CA 90007 USA
[2] Chapman Univ, Sch Pharm, Irvine, CA USA
[3] Harbor UCLA Med Ctr, Div Pediat Infect Dis, Torrance, CA 90509 USA
[4] Lundquist Inst, Dept Pediat, Torrance, CA USA
[5] Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA
[6] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA
[7] Saban Res Inst, Lab Appl Pharmacokinet & Bioinformat, Los Angeles, CA USA
[8] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[9] Childrens Hosp Los Angeles, Div Neonatol, Fetal & Neonatal Inst, Los Angeles, CA 90027 USA
[10] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2021年 / 27卷 / 06期
关键词：
D O I：
10.1016/j.cmi.2021.01.015
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：929 / 930
页数：2
相关论文
共 10 条
  • [1] Cost-benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin
    Lee, Brian, V
    Fong, Gary
    Bolaris, Michael
    Neely, Michael
    Minejima, Emi
    Kang, Amy
    Lee, Grace
    Gong, Cynthia L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1346.e1 - 1346.e7
  • [2] Re: 'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for Vancomycin' by Lee et al.
    Dalton, Bruce
    Rennert-May, Elissa
    Stewart, Jackson
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (06) : 927 - 928
  • [3] Therapeutic drug monitoring versus Bayesian AUC-based dosing for vancomycin in routine practice: a cost-benefit analysis
    Claus, Barbara O. M.
    De Smedt, Delphine
    De Cock, Pieter A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025, 80 (03) : 857 - 867
  • [4] COMPARISON OF VANCOMYCIN AUC VERSUS TROUGH DOSING STRATEGIES ON NEPHROTOXICITY: A META-ANALYSIS
    Crovetto, Brynna
    Brunetti, Luigi
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 345 - 345
  • [5] Trough-guided Versus AUC/MIC-Guided Vancomycin Monitoring: A Cost Analysis
    Morales, Ronaldo
    Tiguman, Gustavo Magno Baldin
    Juodinis, Vanessa D'Amaro
    Santos, Isabela Cristina Pinheiro de Freitas
    Leite, Fernanda Soares
    Vercelino, Jucara Guicardi
    de Lima, Bruna Diniz
    Barbosa, Livia Maria Goncalves
    CLINICAL THERAPEUTICS, 2022, 44 (09) : E91 - E96
  • [6] Making the transition from trough based dosing of vancomycin to area under the curve (AUC) based dosing using Bayesian pharmacokinetic modelling software
    Tannous, E.
    Kewan, W.
    Selitzky, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 264 - 264
  • [7] FEASIBILITY OF TWO-LEVEL VANCOMYCIN AUC-BASED PHARMACOKINETIC MONITORING IN CRITICALLY ILL PATIENTS
    Briscoe, Abigale
    Nelson, Chad
    Sutton, Jesse
    Kerr, Thomas
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 330 - 330
  • [8] Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation
    Suzuki, Ayako
    Samura, Masaru
    Ishigo, Tomoyuki
    Fujii, Satoshi
    Ibe, Yuta
    Yoshida, Hiroaki
    Tanaka, Hiroaki
    Ebihara, Fumiya
    Maruyama, Takumi
    Hamada, Yukihiro
    Fujihara, Hisato
    Yamaguchi, Fumihiro
    Nagumo, Fumio
    Komatsu, Toshiaki
    Tomizawa, Atsushi
    Takuma, Akitoshi
    Chiba, Hiroaki
    Nishi, Yoshifumi
    Enoki, Yuki
    Taguchi, Kazuaki
    Matsumoto, Kazuaki
    PHARMACEUTICAL RESEARCH, 2024, 41 (11) : 2161 - 2171
  • [9] Two-Component Bayesian Hierarchical Models for Cost-Benefit Analysis of Traffic Barrier Crash Count
    Rezapour, Mahdi
    Ksaibati, Khaled
    ALGORITHMS, 2020, 13 (08)
  • [10] Switching Vancomycin Monitoring From Trough Concentration to Area Under the Curve Estimation by Bayesian Forecasting: A Short Communication on a Cost-Benefit Study in Resource-Limited Settings
    Telles, Joao Paulo
    Coelho Jr, Diogenes
    Migotto, Karen Cristina
    Diegues, Mariana Suelotto
    Leao, Erica Rocha
    Reghini, Rodrigo
    Martos, Natalia Martinez
    Caruso, Pedro
    Franca e Silva, Ivan Leonardo
    THERAPEUTIC DRUG MONITORING, 2024, 46 (05) : 681 - 686
1